Pendium

Step 1 of 9

Talkiatry owns the 'online psychiatrist' conversation in AI, but competitors are closing in on insurance-covered care.

With a visibility score of 64, Talkiatry is a top-tier recommendation for medication management, though sentiment risks from billing complaints require active management.

Talkiatry's baseline score
64/100
Good

Talkiatry is currently a category leader for specialized psychiatric discovery, particularly for ADHD. While its medical authority is well-established, growing competition from hybrid platforms like Grow Therapy and sentiment risks from billing-related Reddit threads are the primary threats to its visibility lead.

What we see
  • Talkiatry has a strong 'medication management' signal in AI training data, winning mentions for ADHD-specific queries.
  • The brand's reliance on in-network insurance is its strongest positive attribute across all four major AI platforms.
  • A significant 'billing controversy' signal exists on Reddit and Trustpilot, which AI agents (especially Gemini and AI Overviews) are beginning to surface as risks.
  • Competitors like Talkspace have higher general visibility, but Talkiatry leads in 'board-certified' and 'clinical' associations.
  • Visibility in AI Overviews is currently hampered by the high volume of critical user reviews on third-party aggregators.
Business goals Talkiatry is likely trying to hit
  • Increase market share in specialized ADHD and anxiety medication management
  • Improve billing transparency to reduce negative sentiment and customer churn
  • Expand in-network partnerships with smaller regional insurance payers
  • Differentiate from therapy-only platforms like BetterHelp by emphasizing medical psychiatric expertise